Abstract:Gd(III) chelate is currently used as positive magnetic resonance imaging (MRI) contrast agent in clinical diagnosis, but generally induces the risk of nephrogenic systemic fibrosis (NSF) due to the dissociated Gd3+ from Gd(III) chelates. To develop a novel positive MRI contrast agent with low toxicity and high sensitivity, ultrasmall MnO nanoparticles were PEGylated via catechol-Mn chelation and conjugated with cRGD as active targeting function to tumor. Particularly, the MnO nanoparticles with a size of ca. 5 nm were modified by alpha,beta-poly(aspartic acid)-based graft polymer containing PEG and DOPA moieties and, meanwhile, conjugated with cRGD to produce the contrast agent with a size of ca. 100 nm and a longitudinal relaxivity (r(1)) of 10.2 mM(-1) S-1. Such nanoscaled contrast agent integrated passive- and active-targeting function to tumor, and its efficient accumulation behavior in tumor was verified by in vivo distribution study. At the same time, the PEG moiety played a role of hydrophilic coating to improve the biocompatibility and stability under storing and physiological conditions, and especially might guarantee enough circulation time in blood. Moreover, in vivo MRI revealed a good and long-term effect of enhancing MRI signal for as-fabricated contrast agent while cell viability assay proved its acceptable cytotoxicity for MRI application. On the whole, the as-fabricated PEGylated and cRGD-functionalized contrast agent based on ultrasmall MnO nanoparticles showed a great potential to the T-1-weighted MRI diagnosis of tumor. Crown Copyright (C) 2015 Published by Elsevier B.V. All rights reserved.

Water-dispersible Multiwalled Carbon Nanotube/iron Oxide Hybrids As Contrast Agents for Cellular Magnetic Resonance Imaging

Water-dispersible magnetic carbon nanotubes as T2-weighted MRI contrast agents

Carbon nanotube-based magnetic-fluorescent nanohybrids as highly efficient contrast agents for multimodal cellular imaging

Colloidally stabilized magnetic carbon nanotubes providing MRI contrast in mouse liver tumors.

Fe Doped Magnetic Nanodiamonds Made by Ion Implantation as Contrast Agent for MRI

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Metallic Iron Nanoparticles for MRI Contrast Enhancement and Local Hyperthermia.

Mn(ii) Chelate-Coated Superparamagnetic Iron Oxide Nanocrystals As High-Efficiency Magnetic Resonance Imaging Contrast Agents

Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.

Fe/Mn Multilayer Nanowires As Dual Mode T1 -T2 Magnetic Resonance Imaging Contrast Agents.

Solvothermal Synthesis of Cobalt Ferrite Nanoparticles Loaded on Multiwalled Carbon Nanotubes for Magnetic Resonance Imaging and Drug Delivery

Ultrasmall Water-Soluble Metal-Iron Oxide Nanoparticles As T1-weighted Contrast Agents for Magnetic Resonance Imaging.

Targeted Fe-filled carbon nanotube as a multifunctional contrast agent for thermoacoustic and magnetic resonance imaging of tumor in living mice

Fe5C2 nanoparticles with high MRI contrast enhancement for tumor imaging.

Biomass-Derived Organonanomaterials As Contrast Agents for Efficient Magnetic Resonance Imaging

Biocompatible iron(II)-doped carbon dots as T1-weighted magnetic resonance contrast agents and fluorescence imaging probes

Inorganic Nanoparticle-Based T1 and T1/T2 Magnetic Resonance Contrast Probes.

Folic acid modified superparamagnetic iron oxide nanocomposites for targeted hepatic carcinoma MR imaging

Engineering of Inorganic Nanoparticles As Magnetic Resonance Imaging Contrast Agents.

Gd-complex Labeled Magnetite Nanoparticles As Fluorescent and Targeted Magnetic Resonance Imaging Contrast Agent

Fabrication and Evaluation of Tumor-Targeted Positive MRI Contrast Agent Based on Ultrasmall MnO Nanoparticles.